We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

244 hedge funds and large institutions have $3.12B invested in Axsome Therapeutics in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more call options, than puts

Call options by funds: $79.2M | Put options by funds: $41.4M

83% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 24

30% more funds holding in top 10

Funds holding in top 10: 10 → 13 (+3)

18% more capital invested

Capital invested by funds: $2.65B → $3.12B (+$473M)

8% more funds holding

Funds holding: 226 → 244 (+18)

2.6% more ownership

Funds ownership: 80.28% → 82.88% (+2.6%)

20% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 88

Holders
244
Holders Change
+18
Holders Change %
+7.96%
% of All Funds
3.56%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.19%
New
44
Increased
70
Reduced
88
Closed
24
Calls
$79.2M
Puts
$41.4M
Net Calls
+$37.9M
Net Calls Change
+$18.3M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$62.9M
2
PA
Perceptive Advisors
New York
+$37.2M
3
Millennium Management
Millennium Management
New York
+$27.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$20.4M
5
BlackRock
BlackRock
New York
+$20.4M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$65.3M
2
NIP
Nicholas Investment Partners
California
-$20.9M
3
SCM
Soleus Capital Management
Connecticut
-$16.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$13.8M
5
BI
BVF Inc
California
-$10M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
76
Invesco
Georgia
$3.67M -$1.09M -16,278 -26%
PI
77
Putnam Investments
Massachusetts
$3.62M -$5M -74,780 -62%
Neuberger Berman Group
78
Neuberger Berman Group
New York
$3.53M +$2.96M +44,315 New
CS
79
Credit Suisse
Switzerland
$3.51M -$883K -13,210 -23%
AllianceBernstein
80
AllianceBernstein
Tennessee
$3.29M – – –
UBS Group
81
UBS Group
Switzerland
$3.19M +$491K +7,341 +22%
Carson Wealth (CWM LLC)
82
Carson Wealth (CWM LLC)
Nebraska
$3.05M -$118K -1,759 -4%
State of New Jersey Common Pension Fund D
83
State of New Jersey Common Pension Fund D
New Jersey
$3.03M +$373K +5,576 +17%
MOACM
84
Mutual of America Capital Management
New York
$2.75M -$106K -1,590 -4%
SFG
85
SVB Financial Group
Texas
$2.69M – – –
California State Teachers Retirement System (CalSTRS)
86
California State Teachers Retirement System (CalSTRS)
California
$2.64M -$227K -3,396 -9%
Legal & General Group
87
Legal & General Group
United Kingdom
$2.63M -$59K -883 -3%
SEI Investments
88
SEI Investments
Pennsylvania
$2.62M -$1.88M -28,178 -46%
AA
89
ALPS Advisors
Colorado
$2.59M -$157K -2,346 -7%
Manulife (Manufacturers Life Insurance)
90
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.41M +$665K +9,940 +49%
UBS AM
91
UBS AM
Illinois
$2.39M -$294K -4,391 -13%
DekaBank Deutsche Girozentrale
92
DekaBank Deutsche Girozentrale
Germany
$2.36M – – –
New York State Common Retirement Fund
93
New York State Common Retirement Fund
New York
$2.23M +$204K +3,052 +12%
Macquarie Group
94
Macquarie Group
Australia
$2.19M +$402K +6,009 +28%
PFC
95
Phocas Financial Corp
California
$2.14M +$1.8M +26,890 New
Royal Bank of Canada
96
Royal Bank of Canada
Ontario, Canada
$2.09M +$427K +6,384 +32%
State of Wisconsin Investment Board
97
State of Wisconsin Investment Board
Wisconsin
$2.01M -$263K -3,939 -14%
VOYA Investment Management
98
VOYA Investment Management
Georgia
$1.72M -$2.34M -34,988 -62%
Truist Financial
99
Truist Financial
North Carolina
$1.68M +$1.41M +21,086 New
Simplex Trading
100
Simplex Trading
Illinois
$1.66M +$887K +13,267 +176%
2 3
4
5 6

AXSM Hedge Fund Activity: Q4 2023 in Review

244 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q4 2023, worth a combined $3.12B — up 18% from $2.65B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new AXSM positions and 24 closed out — a net gain of 20 holders — while 70 added to existing stakes and 88 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $62.9M. The largest seller was Fidelity Investments, cutting an estimated $65.3M.

  • 244 institutional investors held Axsome Therapeutics (AXSM) as of Q4 2023, up from 226 in Q3 2023.
  • Funds reported $3.12B of Axsome Therapeutics stock for Q4 2023, up 18% quarter-over-quarter.
  • 44 funds opened new Axsome Therapeutics positions in Q4 2023 and 24 closed out, a net change of +20 holders.
  • The largest Axsome Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $62.9M added.
  • The largest Axsome Therapeutics seller in Q4 2023 was Fidelity Investments, an estimated $65.3M sold.

Based on aggregated 13F filings for Q4 2023.